20 February, 2024

The Aragonese vaccine against tuberculosis could reach the market in 2027 or 2028

Designed by the University of Zaragoza, with the professor of Microbiology and researcher at the IIS Aragón Carlos Martín at the helm, and developed by the Galician biopharmaceutical company Biofabri.
19 February, 2024

The IIS Aragón puts out to tender the Research Unit in Advanced Therapies of Aragón

These therapies are not yet carried out in Aragon and the Department of Health, through the IIS Aragón, has launched a project to implement them in our Community.